Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 26607987)

Published in J Clin Microbiol on November 25, 2015

Authors

Inna Sekirov1, Matthew A Croxen2, Corrinne Ng2, Robert Azana2, Yin Chang2, Laura Mataseje3, David Boyd3, Chand Mangat3, Benjamin Mack4, Manal Tadros4, Elizabeth Brodkin4, Pamela Kibsey5, Aleksandra Stefanovic6, Sylvie Champagne7, Michael R Mulvey3, Linda M N Hoang8

Author Affiliations

1: British Columbia Center for Disease Control Public Health Laboratory, Provincial Health Services Authority, Vancouver, British Columbia, Canada Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
2: British Columbia Center for Disease Control Public Health Laboratory, Provincial Health Services Authority, Vancouver, British Columbia, Canada.
3: Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
4: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada Surrey Memorial Hospital, Fraser Health Authority, Surrey, British Columbia, Canada.
5: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada Royal Jubilee Hospital, Vancouver Island Health Authority, Victoria, British Columbia, Canada.
6: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada Vancouver General Hospital, Vancouver Coastal Health, Vancouver, British Columbia, Canada.
7: Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada St. Paul's Hospital, Providence Health Care, Vancouver, British Columbia, Canada.
8: British Columbia Center for Disease Control Public Health Laboratory, Provincial Health Services Authority, Vancouver, British Columbia, Canada Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, British Columbia, Canada linda.hoang@bccdc.ca.

Articles citing this

Antimicrobial use in animals. Can Vet J (2016) 1.92

Articles cited by this

Basic local alignment search tool. J Mol Biol (1990) 659.07

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05

Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (2014) 44.23

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis (2009) 15.19

Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol (2002) 12.53

Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis (2006) 11.82

Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med (2012) 6.63

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev (2012) 5.65

Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother (1995) 4.71

Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect (2012) 3.58

Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc Natl Acad Sci U S A (1994) 2.92

Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med (2014) 2.87

The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect (2014) 2.65

SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med (2014) 2.51

Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol (2012) 2.24

Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol (2013) 2.22

Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A (2015) 1.99

Pulsed-field gel electrophoresis. Methods Mol Med (1998) 1.94

Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85

MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics (2015) 1.84

Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect (2014) 1.81

The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis (2013) 1.55

Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother (2012) 1.45

Identification and characterization of a novel incompatibility group X3 plasmid carrying bla NDM-1 in Enterobacteriaceae isolates with epidemiological links to multiple geographical areas in China. Emerg Microbes Infect (2012) 1.42

Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J Antimicrob Chemother (2013) 1.39

Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada. Clin Infect Dis (2012) 1.36

Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto. J Antimicrob Chemother (2011) 1.33

Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting. Antimicrob Agents Chemother (2014) 1.27

MLST reveals potentially high-risk international clones of Enterobacter cloacae. J Antimicrob Chemother (2014) 1.26

Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis (2012) 1.20

Lighter: fast and memory-efficient sequencing error correction without counting. Genome Biol (2014) 1.16

Towards a phenotypic screening strategy for emerging β-lactamases in Gram-negative bacilli. Int J Antimicrob Agents (2012) 1.13

IncA/C plasmids: An emerging threat to human and animal health? Mob Genet Elements (2012) 1.07

NDM-1-producing Enterobacteriaceae in a teaching hospital in Shanghai, China: IncX3-type plasmids may contribute to the dissemination of blaNDM-1. Int J Infect Dis (2015) 1.06

Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis (2013) 1.05

Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). Expert Opin Pharmacother (2013) 1.04

Nosocomial transmission of New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in Toronto, Canada. Infect Control Hosp Epidemiol (2012) 1.01

Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill (2014) 1.00

Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol (2012) 0.99

Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother (2013) 0.98

Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae. PLoS One (2012) 0.95

First Canadian outbreak of Enterobacteriaceae-expressing Klebsiella pneumoniae carbapenemase type 3. Can J Infect Dis Med Microbiol (2012) 0.94

Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: Successful establishment of an OXA-48 ST11 clone. Int J Antimicrob Agents (2015) 0.93

Outbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China. PLoS One (2015) 0.89

Diversity and Global Distribution of IncL/M Plasmids Enabling Horizontal Dissemination of β-Lactam Resistance Genes among the Enterobacteriaceae. Biomed Res Int (2015) 0.84

Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012). PLoS One (2015) 0.83

Carbapenem resistance in Canada. CMAJ (2009) 0.83

Confronting carbapenemase-producing Klebsiella pneumoniae. Future Microbiol (2013) 0.82

Detection of Carbapenemase Production in Gram-negative Bacteria. J Lab Physicians (2014) 0.82

Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital. BMC Microbiol (2015) 0.81

Molecular detection of antibiotic resistance genes from positive blood cultures. Methods Mol Biol (2015) 0.77